CASTLE BIOSCIENCES INC (CSTL)
Castle Biosciences TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barretts Esophagus
Castle Biosciences TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barretts Esophagus
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water
Bendix Selects Aeva to Develop Next-Generation Active Safety Production System for Commercial Vehicles
BXP Executes 150,000 Square Foot Lease with McDermott Will & Schulte at 343 Madison Avenue
TD SYNNEX Recognized with Multiple 2026 HPE Partner of the Year Awards Across North America and Europe
Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
HASI Prices $1 Billion of 5.950% Green Senior Unsecured Notes Due 2033
VitalHub Announces Deployments of Referral Management Solutions
Aya Gold & Silver Added to the VanEck Gold Miners ETF (GDX)